Announcement PDF ASX ANNOUNCEMENT 19 February 2026 HITIQ Appoints High-Profile Advisory Board Elite Athletes and MedTech Leader Join to Strengthen PROTEQT™ Platform Key Highlights • Strategic Advisory Board: Three high-profile advisors appointed to strengthen HITIQ's product development and market positioning • Elite Athlete Expertise: Former NRL player and concussion researcher Dr Martin Lang brings unique player perspective and neuroscience credentials • Hockey Validation: Former Hockeyroo Kalindi Commerford adds elite women's sports insight following Hockey Australia partnership • MedTech Leadership: Former BrainEye CEO Richard Nash contributes extensive medical technology and commercialisation experience • Platform Endorsement: Advisory board members to endorse PROTEQT™ technology and support market education initiatives Advisory Board Appointments HITIQ Limited (ASX: HIQ) (HITIQ or the Company) is pleased to announce the appointment of three accomplished advisors to its newly formed Advisory Board, bringing elite sporting credentials, neuroscience research expertise, and medical technology commercialisation experience to support HITIQ's continued growth and product development. The Advisory Board will provide strategic guidance on product development, athlete engagement, market positioning, and commercial expansion whilst endorsing the PROTEQT™ platform across their respective networks and communities. Dr Martin Lang - Neuroscientist and Former NRL Player Dr Martin Lang brings a unique perspective as both a former professional rugby league player and neuroscientist specialising in contact sport-induced traumatic brain injury. Lang played 176 NRL games for Cronulla-Sutherland Sharks and Penrith Panthers between 1996 and 2004, including the 2003 Grand Final victory. He also represented Queensland in 8 State of Origin matches. Having personally experienced multiple concussions during his playing career, Lang completed a PhD in Neuroscience focusing on concussion biomechanics and neurochemistry. He is a research fellow in the Department of Neuroscience with over 20 years of experience in ocular motor science and has published extensively on brain injury in contact sports. Lang's combination of lived playing experience and academic research credentials provides invaluable insight into athlete perspectives on head impact monitoring technology and the clinical validation requirements for widespread adoption across contact sports. Kalindi Commerford - Former Hockeyroo and Concussion Advocate Kalindi Commerford made her Hockeyroos debut in 2016 and represented Australia in 70 international matches including the 2018 World Cup, 2018 Champions Trophy, and FIH Pro League. The midfielder managed a double degree in Communications (Journalism) and Law whilst competing at elite level. In March 2023, Commerford sustained a severe whiplash concussion during club hockey in Queensland that fundamentally changed her perspective on head injuries in sport. The injury left her fully debilitated for months - unable to work, socialise, or perform basic cognitive tasks like reading. Close to two years elapsed before she was cleared to return to sport and work, with persistent symptoms continuing well beyond initial medical expectations. Commerford has since become a prominent voice for concussion awareness and post-concussion syndrome, sharing her recovery journey openly across social media and media interviews. Her advocacy work resonates particularly with athletes, parents, and young people navigating similar experiences. "The reason I keep posting is because every time I do, I get an influx of messages," Commerford has said publicly about her advocacy work. "I just wish I had this succinct information when I was looking for resources myself." Commerford's willingness to share her lived experience - including the debilitating cognitive symptoms, social isolation, and extended recovery timeline - has helped destigmatise concussion reporting and highlighted the serious long-term impacts of head injuries in sport. Her legal background combined with her personal concussion experience provides HITIQ with authentic athlete advocacy and deep understanding of the challenges facing concussion sufferers. As an Advisory Board member, Commerford will leverage her platform and credibility to promote concussion awareness, share educational content about head impact monitoring, and advocate for improved safety protocols across women's and men's sports. Her connection to Hockey Australia strengthens HITIQ's partnership whilst her advocacy experience positions her to authentically communicate PROTEQT™'s value to athletes, families, and sporting organisations. Richard Nash - Former BrainEye CEO and MedTech Executive Richard Nash brings extensive medical technology leadership experience, having served as CEO of BrainEye from 2023 to 2025, where he led the company's transition from sports-focused concussion assessment into broader neurological health monitoring applications. Prior to BrainEye, Nash held senior commercial roles at Medtronic including Neuromodulation Business Leader and has over 20 years of experience in medical device commercialisation, business development, and market expansion. Nash's expertise in scaling health technology companies, navigating regulatory pathways, and building commercial partnerships across healthcare and sports sectors provides HITIQ with valuable strategic guidance for international expansion and product development. Strategic Value The Advisory Board appointments strengthen HITIQ's strategic capabilities across multiple dimensions: • Athlete Credibility: Elite sporting credentials from NRL and Hockeyroos provide authentic athlete endorsement and market credibility • Scientific Validation: Dr Lang's neuroscience research background reinforces PROTEQT™'s evidence- based positioning • Women's Sports Insight: Commerford's experience addresses growing women's elite and community sports markets • MedTech Expertise: Nash's commercialisation experience supports international expansion and regulatory strategy • Market Education: Advisory board members will actively promote PROTEQT™ technology and brain health awareness The Advisory Board complements HITIQ's executive team by providing specialised expertise in areas critical to the Company's commercialisation strategy across elite sports, community participation, and clinical applications. Equity Consideration In consideration for their services, each Advisory Board member will be issued 500,000 performance rights in HITIQ Limited (1,500,000 performance rights in aggregate), for nil cash consideration. The performance rights vest in equal instalments on a bi-annual basis over the term of their respective agreements, subject to leaver provisions. An Appendix 3B will be lodged with the ASX in connection with the issuance of these securities. Leadership Commentary Earl Eddings, Executive Chair, HITIQ said: "We're delighted to welcome Martin, Kalindi, and Richard to HITIQ's Advisory Board. Each brings unique and complementary expertise that will strengthen our product development, market positioning, and commercial growth. Martin's combination of playing experience and neuroscience research provides authentic credibility with athletes and sporting organisations. Kalindi's elite hockey background reinforces our Hockey Australia partnership whilst providing valuable insight into women's sports markets. Richard's medical technology leadership will guide our international expansion and regulatory strategy. Together, they form a powerful advisory team that enhances HITIQ's ability to deliver world-class brain health monitoring technology across all levels of sport." Dr Martin Lang, Advisory Board Member said: "Having experienced multiple concussions during my NRL career, I understand firsthand the importance of objective head impact monitoring. PROTEQT™ represents a significant advancement in athlete safety technology, providing the real-time data that players, coaches, and medical staff need to make informed decisions about head health. I'm excited to support HITIQ in bringing this technology to athletes across all sports and helping to change the culture around concussion management." Kalindi Commerford, Advisory Board Member said: "Having experienced a severe concussion that turned my life upside down, I understand firsthand how debilitating head injuries can be and how crucial early detection and proper management are. I was unable to work or socialise for months, and my symptoms persisted far longer than anyone expected. Every single aspect of my life was impacted and had to change. Technology like PROTEQT™ can provide athletes with objective data about head impacts, empowering them to make informed decisions before injuries reach the point I experienced. I'm passionate about using my platform to raise awareness about concussion risks and to help ensure other athletes have access to the tools and information they need to protect their brain health. I'm proud to support HITIQ in making this technology accessible and in changing the culture around head impact monitoring in sport." Richard Nash, Advisory Board Member said: "HITIQ has developed compelling technology that addresses a critical need in sports safety and brain health monitoring. The PROTEQT™ platform combines robust sensor technology with practical usability, positioning it well for adoption across sporting organisations and clinical applications. I look forward to contributing my medical technology commercialisation experience to support HITIQ's growth strategy and help bring this important technology to broader markets." About PROTEQT™ PROTEQT™, co-developed with Shock Doctor, is HITIQ's concussion management and athlete safety solution that delivers real-time head impact data through an instrumented mouthguard and analytics platform. About HITIQ HITIQ Limited (ASX: HIQ) develops concussion management and athlete safety technology for sport, clinical, and research applications worldwide. The company combines smart mouthguards and analytics platforms to deliver data-driven safety solutions. To learn more about this announcement please visit the HITIQ Investor Hub by clicking HERE Authorised for release by the Board of HITIQ Limited For further information, contact: investors@hitiq.com Forward-Looking Statements Disclaimer This announcement may contain forward-looking statements. Such statements involve known and unknown risks, uncertainties, and other factors that may cause actual outcomes to differ materially. HITIQ does not undertake any obligation to update forward-looking statements, except as required by law.